| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/13/2013 | CN101534833B Nicotinic desensitizers and methods of selecting, testing, and using them |
| 03/13/2013 | CN101534809B Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain |
| 03/13/2013 | CN101531579B Diaromatic compound with bioactivity |
| 03/13/2013 | CN101528671B MTP inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives |
| 03/13/2013 | CN101528239B Ophthalmic aqeous liquid preparation |
| 03/13/2013 | CN101513391B Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
| 03/13/2013 | CN101439068B Chinese medicine granule containing silymarin and preparation method thereof |
| 03/13/2013 | CN101437824B Inhibitors of secretion of hepatitis b virus antigens for treatment of a chronic hepatitis virus |
| 03/13/2013 | CN101434572B Prodrugs of GABA analogs, compositions and uses thereof |
| 03/13/2013 | CN101415686B Amide substituted indazole and benzotriazole derivatives as poly(ADP-ribose)polymerase (PARP) inhibitors |
| 03/13/2013 | CN101346147B Synergistic binder composition, method for making same, and tablets of an active substance and said binder having advantageous hardness and friability |
| 03/13/2013 | CN101346138B Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage |
| 03/13/2013 | CN101304982B Process for the preparation of benzotriazepine derivatives |
| 03/13/2013 | CN101297828B Uses of Petasites tricholobus franch extract in medicament preparation for preventing and controlling cardiovascular and cerebrovascular diseases |
| 03/13/2013 | CN101287374B Process for preparing malathion for pharmaceutical use |
| 03/13/2013 | CN101272848B Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced |
| 03/13/2013 | CN101228169B Macrocyclic inhibitors of hepatitis c virus |
| 03/13/2013 | CN101213281B 新的dha衍生物及其作为药物的用途 Dha new derivatives and their use as medicament |
| 03/13/2013 | CN101213200B Platinum complexes with mononitrile-containing ligands |
| 03/13/2013 | CN101163415B Nutritional supplement for HIV patients |
| 03/13/2013 | CN101134779B Antibodies specific for human CD22 and their therapeutic and diagnostic uses |
| 03/13/2013 | CN101130536B Flavanone compound and uses thereof |
| 03/13/2013 | CN101094848B Organic compounds |
| 03/13/2013 | CN101056862B Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS) |
| 03/13/2013 | CN101035517B Tablets with site, time-controlled gastrointestinal release of active ingredient |
| 03/13/2013 | CN101012189B Crystalline forms of optical enantiomers of modafinil and method for the procution same |
| 03/13/2013 | CA2779085A1 Agonist of p2y2 receptor as a treatment for aortic valve stenosis |
| 03/13/2013 | CA2752008A1 Combination therapy using ribavirin as elf4e inhibitor |
| 03/12/2013 | US8394990 Phenylurea inhibitors of the enzyme SOAT-1 and pharmaceutical/cosmetic compositions comprised thereof |
| 03/12/2013 | US8394979 Process for preparing cycloplatinated platinum complexes, platinum complexes prepared by this process and the use thereof |
| 03/12/2013 | US8394971 Indole derivatives as selective androgen receptor modulators (SARMS) |
| 03/12/2013 | US8394969 Cyclic benzimidazole derivatives useful as anti-diabetic agents |
| 03/12/2013 | US8394968 Hepatitis C virus inhibitors |
| 03/12/2013 | US8394960 Thiazole carboxamide derivatives and their use to treat cancer |
| 03/12/2013 | US8394953 Compounds and methods for enzyme-mediated tumor imaging and therapy |
| 03/12/2013 | US8394950 Analogues of coformycin and their use for treating protozoan parasite infections |
| 03/12/2013 | US8394947 has a plurality of modified ribofuranosyl nucleosides at defined locations; comprise double stranded constructs wherein one of the strands capable of hybridizing to a nucleic acid target |
| 03/12/2013 | US8394930 Growth factor isoform |
| 03/12/2013 | US8394860 Methods and related compositions using specific flavonoids and indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals |
| 03/12/2013 | US8394859 Combretastatin analogs with tubulin binding activity |
| 03/12/2013 | US8394858 Cyclohexane derivatives and uses thereof |
| 03/12/2013 | US8394857 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases |
| 03/12/2013 | US8394856 (-)-Hydroxycitric acid for controlling inflammation |
| 03/12/2013 | US8394855 Cosmetic compositions |
| 03/12/2013 | US8394854 Use of L-carnitine for the treatment of cardiovascular diseases |
| 03/12/2013 | US8394853 Substituted aminopropionic derivatives as neprilysin inhibitors |
| 03/12/2013 | US8394852 Inotilone derivatives as coherent biological response modifier (cBMR) |
| 03/12/2013 | US8394850 Fluorescent probe specific to hydrogen peroxide |
| 03/12/2013 | US8394849 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 03/12/2013 | US8394848 Compounds that modulate intracellular calcium |
| 03/12/2013 | US8394847 Methods of treating an inflammatory-related disease |
| 03/12/2013 | US8394844 EP4 agonist |
| 03/12/2013 | US8394843 Substituted isoindoles as glucokinase activators |
| 03/12/2013 | US8394842 Benzothiazoles having histamine H3 receptor activity |
| 03/12/2013 | US8394841 Compounds and methods for modulating G protein-coupled receptors |
| 03/12/2013 | US8394840 Modulators of sperm hypermotility and uses thereof |
| 03/12/2013 | US8394839 Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution |
| 03/12/2013 | US8394837 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 03/12/2013 | US8394836 Indoles and their therapeutic use |
| 03/12/2013 | US8394835 Aromatic compounds and their use in medical applications |
| 03/12/2013 | US8394834 Pyrrolidines as NK3 receptor antagonists |
| 03/12/2013 | US8394833 Methods of treating emesis using growth hormone secretagogues |
| 03/12/2013 | US8394832 Methods and compositions using immunomodulatory compounds for the treatment of immunodeficiency disorders |
| 03/12/2013 | US8394831 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/12/2013 | US8394830 Quinolines and their therapeutic use |
| 03/12/2013 | US8394829 Bi-functional quinoline analogs |
| 03/12/2013 | US8394828 Quinoline-derived amide modulators of vanilloid VR1 receptor |
| 03/12/2013 | US8394827 Inhibitor of the differentiation of T cells into Th1 cells |
| 03/12/2013 | US8394826 Dual mechanism inhibitors for the treatment of disease |
| 03/12/2013 | US8394825 Compound |
| 03/12/2013 | US8394824 Quinuclidine compounds having quaternary ammonium group, its preparation method and use as blocking agents of acetylcholine |
| 03/12/2013 | US8394823 Triazolopyridine compounds useful as DGAT1 inhibitors |
| 03/12/2013 | US8394822 Thieno-pyridine derivatives as MEK inhibitors |
| 03/12/2013 | US8394821 Activated blood coagulation factor inhibitor |
| 03/12/2013 | US8394820 N-azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/12/2013 | US8394819 Indole derivatives as CRTH2 receptor antagonists |
| 03/12/2013 | US8394818 Soluble mTOR complexes and modulators thereof |
| 03/12/2013 | US8394817 CCR1 antagonists and methods of use therefor |
| 03/12/2013 | US8394816 Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia |
| 03/12/2013 | US8394815 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 03/12/2013 | US8394814 Method of purifying crude noscapine |
| 03/12/2013 | US8394813 Active agent delivery systems and methods for protecting and administering active agents |
| 03/12/2013 | US8394812 Sustained release formulations of nalbuphine |
| 03/12/2013 | US8394811 Hydrazide compounds as thyroid hormone receptor modulators and uses thereof |
| 03/12/2013 | US8394810 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof |
| 03/12/2013 | US8394809 Phenoxy-substituted pyrimidines as opioid receptor modulators |
| 03/12/2013 | US8394808 HM74 receptor agonists:xanthine derivatives, corresponding pharmaceutical compositions, treatment methods and processes |
| 03/12/2013 | US8394807 Quinazoline inhibitors of BACE 1 and methods of using |
| 03/12/2013 | US8394806 2-phenyl pyrazines as tubulin inhibitors |
| 03/12/2013 | US8394805 Compounds |
| 03/12/2013 | US8394804 Phosphonic acid compounds as inhibitors of serine proteases |
| 03/12/2013 | US8394803 Gyrase inhibitors and uses thereof |
| 03/12/2013 | US8394802 3,4-dihydro-2H-pyrrolo[1,2-a]pyrazin-1-one derivatives for the modulation of the activity of protein kinases |
| 03/12/2013 | US8394801 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders |
| 03/12/2013 | US8394800 Method for treating psoriasis |
| 03/12/2013 | US8394799 Compounds that inhibit HIF-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component |
| 03/12/2013 | US8394797 Substituted pyrazole sigma receptor antagonists |
| 03/12/2013 | US8394796 Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use |
| 03/12/2013 | US8394795 Pyrazole [3, 4-B] pyridine Raf inhibitors |
| 03/12/2013 | US8394794 Therapeutic compounds |